Wei Binxian bought PALI
June 10, 2026 · Form 4 insider transaction
Wei Binxian bought 592,300 shares of Palisade Bio, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
592,300
Price
N/A
Total value
N/A
InsiderWei Binxian
Role—
CompanyPalisade Bio, Inc. (PALI)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 10, 2026
Filing dateJune 12, 2026
Shares owned after593,155
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date.